Ontology highlight
ABSTRACT: Funding
This work was unsponsored and unfunded.Tweetable abstract
Randomised trials should demonstrate more benefit than harm before widespread postpartum low-molecular-weight heparin is recommended.
SUBMITTER: Kotaska A
PROVIDER: S-EPMC6055738 | biostudies-literature | 2018 Aug
REPOSITORIES: biostudies-literature
BJOG : an international journal of obstetrics and gynaecology 20180307 9
Based on prediction models and expert opinion, most obstetric venous thromboembolism guidelines recommend low-molecular-weight heparin for many postpartum women, including most delivering by caesarean. Scrutiny reveals major oversights: prediction models are based on studies that report asymptomatic deep vein thrombosis; risk estimates are not adjusted for time exposure; and harm caused by heparin has been overlooked. The benefits of heparin are exaggerated and its harms are under-appreciated. E ...[more]